<DOC>
	<DOCNO>NCT00514384</DOCNO>
	<brief_summary>Evaluation serial measurement novel biomarker diagnosis , prognosis therapy monitoring patient present acute decompensated heart failure .</brief_summary>
	<brief_title>Serial Measurements Biomarker Patients With Acute Decompensated Heart Failure</brief_title>
	<detailed_description>Background : Heart failure ( HF ) chronic progressive illness result variety cardiac cause , include ischemic valvular heart disease , dilatative cardiomyopathy hypertension . HF may also develop suddenly , particularly complication acute myocardial infarction acute exacerbation patient previously compensate chronic HF . Diagnosis in-hospital management HF often demand outcome especially regard rehospitalizations impair . Novel biomarker may helpful assessment diagnosis , prognosis , severity HF well treatment monitoring . Design : Prospective , multicenter observational study Setting : University Hospital Basel , Kantonsspital Aarau , Kantonsspital Luzern , Kantonsspital Wolhusen Patients : Patients acute HF require ICU admission Measurement serial biomarker ( BNP , NT-proBNP , MR-proADM , ST2 , hs-cTnI Copeptin ) perform presentation , 6 hour ( h ) , 12h , 18h , 24h , 48h , day 6 hospital discharge . Follow- perform 6 Month , 1 year 2 year .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Acute HF Informed consent Cardiogenic shock , STelevation myocardial infarction , clinical condition require immediate ICU admission urgent PTCA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>